20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Clover Health Investments Corp (CLOV) operates in the HEALTHCARE PLANS industry and is headquartered in Wilmington, United States with about 724 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, CLOV reported $1.9B in revenue and ($86M) in net income.
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals.
Interactive charts & full statements → Open the CLOV valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.5B | $1.9B | $1.4B | $1.3B | $1.1B | $1.5B | $673M | $462M | $281M |
| Gross Profit | $460M | $356M | $365M | $256M | $103M | ($79M) | $83M | $13M | $281M |
| Gross Margin % | 18.6% | 18.5% | 26.6% | 20.3% | 9.4% | -5.4% | 12.3% | 2.7% | 100.0% |
| Operating Income (EBIT) | ($18M) | ($86M) | ($46M) | ($205M) | ($287M) | ($637M) | ($93M) | ($183M) | ($186M) |
| Operating Margin % | -0.7% | -4.4% | -3.3% | -16.3% | -26.1% | -43.3% | -13.8% | -39.6% | -66.1% |
| Net Income | ($18M) | ($86M) | ($43M) | ($213M) | ($340M) | ($588M) | ($136M) | ($364M) | ($202M) |
| Net Margin % | -0.7% | -4.5% | -3.1% | -16.9% | -31.0% | -39.9% | -20.3% | -78.7% | -71.9% |
| EBITDA | ($16M) | ($84M) | ($45M) | ($208M) | ($252M) | ($570M) | ($79M) | ($324M) | ($16M) |
| Earnings Per Share (EPS) | $-0.04 | $-0.17 | $-0.09 | $-0.44 | $-0.71 | $-1.25 | $-0.34 | $-0.90 | $-4.81 |
| Shares Outstanding (M) | 545M | 517M | 490M | 482M | 476M | 471M | 404M | 404M | 42M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $743M | $749M | $488M | $497M | $478M | $462M | $337M | $331M |
| Gross Profit | $153M | $160M | $74M | $73M | $100M | $109M | $94M | $81M |
| Gross Margin % | 20.6% | 21.3% | 15.2% | 14.7% | 20.9% | 23.5% | 27.9% | 24.5% |
| Operating Income (EBIT) | $28M | $27M | ($49M) | ($24M) | ($11M) | ($1M) | ($21M) | ($9M) |
| Operating Margin % | 3.8% | 3.6% | -10.1% | -4.9% | -2.2% | -0.3% | -6.4% | -2.6% |
| Net Income | $28M | $27M | ($49M) | ($24M) | ($11M) | ($1M) | ($22M) | ($9M) |
| Net Margin % | 3.8% | 3.6% | -10.1% | -4.9% | -2.2% | -0.3% | -6.6% | -2.8% |
| EBITDA | $29M | $28M | ($49M) | ($24M) | ($10M) | ($1M) | ($21M) | ($9M) |
| Earnings Per Share (EPS) | $0.05 | $0.05 | $-0.10 | $-0.05 | $-0.02 | $-0.00 | $-0.04 | $-0.02 |
| Shares Outstanding (M) | 545M | 533M | 517M | 513M | 509M | 497M | 492M | 490M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $77M | ($67M) | $35M | ($116M) | ($204M) | ($282M) | ($118M) | ($160M) | ($153M) |
| Capital Expenditures (CapEx) | $3M | $2M | $2M | $1M | $4M | $1M | $1M | $0M | $1M |
| Free Cash Flow (FCF) | $74M | ($69M) | $33M | ($116M) | ($208M) | ($283M) | ($119M) | ($160M) | ($155M) |
| FCF Margin % | 3.0% | -3.6% | 2.4% | -9.2% | -19.0% | -19.2% | -17.7% | -34.6% | -55.1% |
| Dividends Paid | — | — | — | — | — | $0M | $1M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $25M | $108M | ($68M) | $12M | $5M | ($16M) | ($86M) | $50M |
| Capital Expenditures (CapEx) | $1M | $1M | $1M | $1M | $1M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | $25M | $107M | ($69M) | $11M | $5M | ($16M) | ($86M) | $50M |
| FCF Margin % | 3.3% | 14.3% | -14.1% | 2.3% | 1.0% | -3.6% | -25.6% | 15.0% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $720M | $541M | $581M | $571M | $809M | $951M | $267M | $0M | $211M |
| Cash & Cash Equivalents | $199M | $78M | $195M | $116M | $104M | $300M | $92M | $68M | $75M |
| Total Liabilities | $344M | $232M | $240M | $284M | $452M | $411M | $880M | $0M | $265M |
| Total Debt (Short + Long-Term) | $0M | $0M | $0M | $2M | $2M | $23M | $132M | $0M | $0M |
| Total Shareholders' Equity | $376M | $309M | $341M | $286M | $357M | $535M | ($617M) | $0M | ($55M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CLOV viewer.
About TickerBase · Data methodology & sources · Privacy · Terms